An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to coronavirus disease (COVID-19), a global health pandemic causing millions of deaths worldwide. However, the immunopathogenesis of COVID-19, particularly the interaction between SARS-CoV-2 and host innate immunit...
Enregistré dans:
Auteurs principaux: | Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/481e8539bb824e7da5e1c5b29b4caeea |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Activation of Toll-Like Receptors by Live Gram-Negative Bacterial Pathogens Reveals Mitigation of TLR4 Responses and Activation of TLR5 by Flagella
par: Kei Amemiya, et autres
Publié: (2021) -
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
par: Amani E. Khalifa, PhD, et autres
Publié: (2021) -
Toll-Like Receptor 4 and Inflammatory Micro-Environment of Pancreatic Islets in Type-2 Diabetes Mellitus: A Therapeutic Perspective
par: Wang Z, et autres
Publié: (2020) -
Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
par: Hi Eun Jung, et autres
Publié: (2021) -
Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
par: Kelsey A. Gregg, et autres
Publié: (2017)